Seven-day triple therapy with ranitidine bismuth citrate or omeprazale and two antibiotics for eradication of Helicobacter pylori in duodenal ulcer: A multicentre, randomized single-blind study

Alimentary Pharmacology and Therapeutics

Volumn 14, Issue 3, 2000, Pages 325-330

  Spinzi, ^a   Boni, ^b   Bortoli, ^b   Colombo, ^b   Ballardini, ^b   Venturelli, ^b   Minoli, ^a  

^a Valduce Hospital Como   (Italy)

^b Department of Internal Medicine ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; OMEPRAZOLE; RANITIDINE BISMUTH CITRATE; UREA;

ADULT; AGED; ARTICLE; BREATH ANALYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DUODENUM ULCER; ERADICATION THERAPY; FEMALE; HELICOBACTER PYLORI; HUMAN; INTESTINE INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMATITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; BISMUTH; CLARITHROMYCIN; DUODENAL ULCER; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PATIENT COMPLIANCE; PENICILLINS; PROSPECTIVE STUDIES; RANITIDINE; SINGLE-BLIND METHOD;

EID: 0034014788     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2000.00708.x     Document Type: Article

References (30)

1. 1 The European Helicobacter pylori study group. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report Gut 1997; 41: 8-13.
2. 2 Lind T, Van Veldhuyzen Zanten S, Unge P, et al. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH 1 study. Helicobacter 1996; 1: 138-44.
3. 3 Laine L, Frantz JE, Baker A, Neil GA. A United States multi-centre trial of dual and proton pump inhibitor-based triple therapies for Helicobacter pylori. Aliment Pharmacol Ther 1997; 11: 913-7.
4. 4 Yousfy MM, El-Zimaity HMT. Genta RM, Graham DY. One week triple therapy with omeprazole, amoxycillin and clarithromycin for treatment of Helicobacter pylori infection. Aliment Pharmacol Ther 1996; 10: 617-21.
5. 5 Schwarte H, Krause R, Siepman N, et al. Seven-day triple therapy with lansoprazolc, clarithromycin, and metronidazole for the cure of Helicobacter pylori infection: a short report. Helicobacter 1996; 1: 251-5.
6. 6 Stables R, Campbell CJ, Clayton NM. et al. Gastric anti-secretory, mucosal protective, anti-pepsin and anti-Helicobacter properties of ranitidine bismuth citrate. Aliment Pharmacol Ther 1993; 7: 237-46.
7. 7 Hopkins RJ. Current FDA-approved treatments for Helicobacter pylori and the FDA approval process. Gastroenterology 1997; 113(Suppl. 6): 126-30.
8. 8 Axon ATR, Ireland A, Lancaster-Smith MJ, Roopram PD. Ranitidine bismuth citrate and clarithromycin twice daily in the eradication of Helicobacter pylori. Aliment Pharmacol Ther 1997; 11: 81-7.
9. 9 Peterson WL, Sontag SJ, Ciociola AA, et al. Ranitidine bismuth citrate plus clarithromycin is effective in the eradication of Helicobacter pylori and prevention of ulcer relapse. Aliment Pharmacol Ther 1996; 10: 251-61.
10. 10 Spadaccini A, De Fanis C, Sciampa G, et al. Triple regimens using lansoprazole or ranitidine bismuth citrate for Helicobacter pylori eradication. Aliment Pharmacol Ther 1998; 12: 997-1001.
11. 11 Savarino S, Mansi C, Mele MR, et al. A new 1-week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus two antibiotics. Aliment Pharmacol Ther 1997; 11: 699-703.
12. 12 Williams M, Hamilton MR, Sercombe JC, Pounder RE. Seven day treatment for Helicobacter pylori infection: ranitidine bismuth citrate plus clarithromycin and tetracycline hydrochloride. Aliment Pharmacol Ther 1997; 11: 705-10.
13. 13 Karim ON, Logan RPH. Helicobacter pylori antimicrobial resistance in the UK. Gut 1996; 39: 15(Abstract).
14. 14 Laine L, Estrada R, Trujillo M, Emami S. Randomized comparison of Ranitidine Bismuth Citrate-based triple therapies for Helicobacter pylori. Am J Gastroenterol 1997; 92: 221 3-5.
15. 15 Bardhan KD, Wurzer H, Marcelino M, et al. Ranitidine bismuth citrate with clarithromycin given twice daily effectively eradicates Helicobacter pylori and heals duodenal ulcers. Am J Gastroenterol 1998; 93: 380-5.
16. 16 Pipkin GA, Williamson R, Wood JR. Review article: one-week clarithromycin triple therapy regimens for eradication of Helicobacter pylori. Aliment Pharmacol Ther 1998; 12: 823-37.
17. 17 Sung JJY, Leung WK, Ling TKW, et al. One-week use of ranitidine bismuth citrate, amoxycillin and clarithromycin for the treatment of Helicobacter pylori-related duodenal ulcer. Aliment Pharmacol Ther 1998; 12: 725-30.
18. 18 Catalano F, Catanzaro R, Bentivegna C, et al. Ranitidine bismuth citrate versus omeprazole therapy for eradication of Helicobacter pylori and healing of duodenal ulcer. Aliment Pharmacol Ther 1998; 12: 59-62.
19. 19 Bigard MA, Delchier JC, Riachi G, et al. One-week triple therapy using omeprazole, amoxycillin and clarithromycin for the eradication of Helicobacter pylori in patients with non-ulcer dyspepsia: influence of dosage of omeprazole and clarithromycin. Aliment Pharmacol Ther 1998; 12: 383-8.
20. 20 Lamouliatte H, The Aquitaine-Gastro Association, De Mascarel A. et al. Double-blind study comparing once daily versus twice daily dosage of PPI with amoxicillin-clarithromycin for H. pylori cure. Gut 1997; 41(Suppl. 1): A93 (Abstract).
21. 21 Ruszniewsky P, Lamouliatte H, Flejou JF, et al. Evaluation of short term ranitidine versus omeprazole triple therapy regimens for eradication of Helicobacter pylori in duodenal ulcer patients. Gut 1997; 41(Suppl. 1): A94(Abstract).
22. 22 Mcgraud F, Lehn N, Lind T, et al. The Mach 2 study: Helicobacter pylori resistance to antimicrobial agents and its influence on clinical outcome. Gastroenterology 1997; 112: A216(Abstract).
23. 23 Mcgraud F, Occhialini A. Mode d'action des macrolides et mecanisme de resistance chez Helicobacter pylori. La Lettre de L'infectiologue 1997; 12: 5-9.
24. 24 Wurzer H, Rodrigo L, Archimbault A, et al. Short course therapy with amoxicillin, clarithromycin triple for 10 days (ACT-10) eradicates H. pylori and heals duodenal ulcer. Gut 1996; 39(Suppl. 2): A38(Abstract).
25. 25 Parè P, Romaozinho J, Bardhan HD, et al. Ranitidine bismuth citrate (RBC) is more effective than omeprazole in the eradication of Helicobacter pylori when co-prescribed with clarithromycin. Gastroenterology 1997; 112: A251(Abstract).
26. 26 Megraud F, Pichavant R, Palegry D, et al. Ranitidine bismuth citrate (RBC) co-prescribed with clarithromycin is more effective in the eradication of Helicobacter pylori than omeprazole with clarithromycin. Gut 1997; 41(Suppl. 2): A92(Abstract).
27. 27 Dore MP. Osato MS, Reddy SG. Susceptibility of amoxicillin-resistant Helicobacter pylori to different B-lactam antibiotics. DDW, New Orleans 1998; A279: 1130.
28. 28 Jaup B, Norrby A. Comparison of two low-dose one-week triple therapy regimens with and without metronidazole for cure of H. pylori. Aliment Pharmacol Ther 1996; 10: 275-7.
29. 29 Harris AW, Misiewicz JJ, Bardhan KD. et al. Incidence of duodenal ulcer healing after 1 week of proton pump inhibitor triple therapy for eradication of Helicobacter pylori. Aliment Pharmacol Ther 1998; 12: 741-5.
30. 30 Logan RPH, Gummett PA, Misiewicz JJ, et al. One week's antiHelicobacter pylori treatment for duodenal ulcer. Gut 1994; 35: 15-8.